Sandra Dudareva

762 total citations
44 papers, 415 citations indexed

About

Sandra Dudareva is a scholar working on Epidemiology, Hepatology and Microbiology. According to data from OpenAlex, Sandra Dudareva has authored 44 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 27 papers in Hepatology and 10 papers in Microbiology. Recurrent topics in Sandra Dudareva's work include Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (22 papers) and Hepatitis Viruses Studies and Epidemiology (11 papers). Sandra Dudareva is often cited by papers focused on Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (22 papers) and Hepatitis Viruses Studies and Epidemiology (11 papers). Sandra Dudareva collaborates with scholars based in Germany, Sweden and Denmark. Sandra Dudareva's co-authors include Ulrich Marcus, Viviane Bremer, Karin Haar, Hilmar Wisplinghoff, Klaus Jansen, Matthias an der Heiden, Ruth Zimmermann, Susanne Buder, Gyde Steffen and Judith Koch and has published in prestigious journals such as PLoS ONE, Emerging infectious diseases and BMC Public Health.

In The Last Decade

Sandra Dudareva

37 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Dudareva Germany 12 204 179 129 128 116 44 415
J Ochnio Canada 12 276 1.4× 136 0.8× 148 1.1× 121 0.9× 25 0.2× 24 435
Ana Fuentes Spain 10 191 0.9× 139 0.8× 178 1.4× 176 1.4× 28 0.2× 37 480
G S Underhill United Kingdom 10 249 1.2× 155 0.9× 89 0.7× 58 0.5× 30 0.3× 15 376
Chrysovalantis Stafylis United States 12 151 0.7× 144 0.8× 23 0.2× 180 1.4× 154 1.3× 29 375
Marie-Christine Defer Burkina Faso 7 325 1.6× 120 0.7× 21 0.2× 172 1.3× 40 0.3× 10 444
Maria Cristina Salfa Italy 11 199 1.0× 53 0.3× 45 0.3× 161 1.3× 27 0.2× 30 301
Stine Nielsen Germany 12 283 1.4× 55 0.3× 133 1.0× 188 1.5× 18 0.2× 36 439
Joumana Hermez Egypt 9 208 1.0× 43 0.2× 82 0.6× 111 0.9× 23 0.2× 24 275
Belinda Hengel Australia 12 154 0.8× 232 1.3× 14 0.1× 109 0.9× 136 1.2× 33 442
Octavio Mesner United States 10 145 0.7× 39 0.2× 42 0.3× 92 0.7× 44 0.4× 17 316

Countries citing papers authored by Sandra Dudareva

Since Specialization
Citations

This map shows the geographic impact of Sandra Dudareva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Dudareva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Dudareva more than expected).

Fields of papers citing papers by Sandra Dudareva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Dudareva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Dudareva. The network helps show where Sandra Dudareva may publish in the future.

Co-authorship network of co-authors of Sandra Dudareva

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Dudareva. A scholar is included among the top collaborators of Sandra Dudareva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Dudareva. Sandra Dudareva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Sperle, Ida, Zuridin Sharipovich Nurmatov, Stela Bivol, et al.. (2025). Barriers and Facilitators to HIV and Viral Hepatitis Testing in Primary Health Care Settings in the Kyrgyz Republic (BarTest): Protocol for a Mixed Methods Study. JMIR Research Protocols. 14. e62929–e62929. 1 indexed citations
7.
Sperle, Ida, Sofie Gillesberg Lassen, Martin Schlaud, et al.. (2024). Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014–2017. BMC Infectious Diseases. 24(1). 318–318.
8.
Mazhnaya, Alyona, Krestina Brigida, Shokhista Bakieva, et al.. (2024). Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population. BMC Public Health. 24(1). 1482–1482. 1 indexed citations
10.
Maisa, Anna, Christian Kollan, Matthias an der Heiden, et al.. (2021). Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019. Frontiers in Public Health. 9. 667253–667253. 2 indexed citations
11.
Steffen, Gyde, Ida Sperle, Thomas Harder, et al.. (2021). Hepatitis B vaccination coverage in Germany: systematic review. BMC Infectious Diseases. 21(1). 817–817. 9 indexed citations
12.
Diercke, Michaela, et al.. (2020). Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016. Epidemiology and Infection. 148. e36–e36. 5 indexed citations
13.
Zimmermann, Ruth, Mirko Faber, Sandra Dudareva, et al.. (2020). Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: Epidemiology, management, and successful interventions. International Journal of Infectious Diseases. 103. 146–153. 16 indexed citations
14.
Altmann, Doris, Matthias an der Heiden, Viviane Bremer, et al.. (2020). Evaluation of the German surveillance system for hepatitis B regarding timeliness, data quality, and simplicity, from 2005 to 2014. Public Health. 180. 141–148. 3 indexed citations
15.
Jacob, Josephine, Sandra Dudareva, Klaus Jansen, et al.. (2020). Gelingt das Screening von Schwangeren auf HIV, Syphilis und Hepatitis B in Deutschland? Eine Analyse auf Basis von Routinedaten. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63(9). 1143–1150. 1 indexed citations
16.
Steffen, Gyde, Ida Sperle, Siv Aina J. Leendertz, et al.. (2020). The epidemiology of Hepatitis B, C and D in Germany: A scoping review. PLoS ONE. 15(3). e0229166–e0229166. 11 indexed citations
17.
Meurs, Lynn, Sandra Dudareva, Michaela Diercke, et al.. (2019). Hepatitis-C-Meldedaten nach IfSG, 2016 – 2018: Auswirkungen der Änderungen von Falldefinition und Meldepflicht. Robert-Koch-Institut (RKI). 3 indexed citations
18.
Heiden, Matthias an der, et al.. (2018). Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in Germany. BMC Infectious Diseases. 18(1). 424–424. 9 indexed citations
19.
Buder, Susanne, et al.. (2018). Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance. BMC Infectious Diseases. 18(1). 44–44. 22 indexed citations
20.
Haar, Karin, Sandra Dudareva, Hilmar Wisplinghoff, et al.. (2013). Lymphogranuloma Venereum in Men Screened for Pharyngeal and Rectal Infection, Germany. Emerging infectious diseases. 19(3). 488–492. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026